Relevant bibliographies by topics / Partners of cancer patients

Academic literature on the topic 'Partners of cancer patients'

Author: Grafiati
Published: 4 June 2021
Last updated: 20 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Partners of cancer patients.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Partners of cancer patients"

1

Giuliani, Meredith Elana, Maurene McQuestion, Lorna Sampson, Lisa W. Le, Jennifer M. Jones, Terry Cheng, John N. Waldron, and Jolie Ringash. "Partner’s survivorship care needs: Multivariable analysis in head and neck cancer patients." Journal of Clinical Oncology 34, no. 3_suppl (January 20, 2016): 120. http://dx.doi.org/10.1200/jco.2016.34.3_suppl.120.

Full text
Abstract:
120 Background: The purpose of this study was to determine the number and predictors of head and neck cancer (HNC) survivors’ partners unmet needs and how they correspond to the unmet needs of the survivor. Methods: This study accrued consenting partners from among 158 patients with HNC who had completed a onetime survey including demographic information and the Cancer Survivors’ Unmet Needs Measure (CaSUN) between January 2013 and May 2014. Patients’ caregivers were invited to complete the Cancer Survivors’ Partners Unmet Needs Survey (CaSPUN). The mean (± standard deviation) number and proportion of unmet needs on the CaSPUN was calculated. Multivariable analyses (MVA) were performed to determine factors associated with greater unmet needs using linear regression. Kappa co-efficient was calculated to examine the agreement between the unmet needs of patients and their partners on 22 corresponding items. Results: The CaSPUN survey was completed by 44 partners of head and neck cancer survivors. At least one unmet need was reported by 29 partners and 4 had a very high number of needs between 31 and 35. The most common unmet needs were “I need help to manage my concerns about the cancer coming back” (41%), “I need more accessible hospital parking” (34%), “ I need help to cope with others not acknowledging the impact of having a partner experience cancer has had on my own life” (30%), “ I need help dealing with changes that cancer has caused in my partner” (27%) and “I need to know all my partners doctors talk to each other to coordinate my partner’s care” (27%). Of the 5 most common items, 3 were in the Relationships domain. On MVA increasing number of unmet needs in patients was significantly associated with increased unmet needs in their partners (p < 0.01). Of the 22 paired items there was fair agreement in 12 items, moderate agreement in 8 items and good agreement in 2 items between patients and partners. Conclusions: A significant proportion of partners of cancer patients experience unmet needs which may differ from those of the patient themselves. Survivorship program should consider independent needs assessment and program development for partners.
APA, Harvard, Vancouver, ISO, and other styles
2

Pat-Horenczyk, R., D. Machyevsky, D. Brom, I. Schwartz, M. Inbar, A. Rice, I. Wexler, and B. Corn. "Dyadic coping among breast cancer patients treated with radiotherapy." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): e20589-e20589. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e20589.

Full text
Abstract:
e20589 Background: Cancer poses a major stressor for patients and their partners. Understanding dyad coping is useful for determining if one partner's involvement is beneficial or harmful to the other. We sought to evaluate whether dyadic coping enhances resilience in the context of other risk and protective factors for coping with serious illness. Methods: An IRB-approved questionnaire was offered to breast cancer patients and their spouses. Consent was obtained from 21 dyads who were queried prior to initiation of breast irradiation and within 2 weeks of completing treatment. The nature of dyadic coping (positive or negative), level of posttraumatic stress, functional impairment, depression, and markers of resiliency were assessed for each partner at the beginning and conclusion of therapy. Results: Depression was significantly higher in patients than in their spouses (df = 1, 13; F = 6.13; p = 0.028). Over the course of the radiotherapy, partner's depression improved while the patient's depression worsened (df=1,13; F=5.46; p=0.030). The patient's negative dyadic coping assessment before radiation therapy was positively associated with depression (β = 0.78; df = 31.3; t = 2.15; p = 0.04), as well as the partner's depression (β = 0.92; df = 31.3; t = 2.52; p = 0.017) and posttraumatic stress (β = 0.74; df = 31.7; t = 2.10; p = 0.04). Patient's pre-radiation negative dyadic coping was negatively associated with the partner's flexibility (β = -.21; df = 19; t = -2.28; p = 0.03) and self efficacy (β = 0.46; df = 21.8; t = 2.96; p = 0.007) at completion of therapy. Positive dyadic coping assessment was not associated with negative coping behaviors on the part of either the patient or partner. Conclusions: The results of this pilot study support interventions incorporating dyadic support to enhance the resilience of patients and partners. Intervention should promote flexibility and self-efficacy while providing tools for altering negative dyadic coping patterns. No significant financial relationships to disclose.
APA, Harvard, Vancouver, ISO, and other styles
3

Sjövall, Katarina, Bo Attner, Thor Lithman, Dennis Noreen, Barbro Gunnars, Bibbi Thomé, and Håkan Olsson. "Influence on the Health of the Partner Affected by Tumor Disease in the Wife or Husband Based on a Population-Based Register Study of Cancer in Sweden." Journal of Clinical Oncology 27, no. 28 (October 1, 2009): 4781–86. http://dx.doi.org/10.1200/jco.2008.21.6788.

Full text
Abstract:
Purpose To examine health care use and health care costs among partners of persons with cancer. Patients and Methods Partners of patients with colon, rectal, lung, breast, and prostate cancer (N = 11,076) were identified via linked data from the Tumor Registry of Southern Sweden and Census Registry of Sweden. Health care use, total costs of health care, and diagnosis of the partner were studied before and after diagnosis of the cancer patient. Results Health care use for partners increased in terms of in-patient care after the cancer diagnosis. A significant increase was seen the second year for partners of patients with colon cancer (risk ratio [RR], 1.55; 95% CI, 1.28 to 1.87) and lung cancer (RR, 1.50; 95% CI, 1.26 to 1.79). Psychiatric diagnoses increased after the cancer diagnosis in the total sample, with a significant increase for partners of colon (RR, 2.66; 95% CI, 1.71 to 4.22), lung (RR, 3.16; 95% CI, 2.23 to 4.57), and prostate cancer patients (RR, 1.68; 95% CI, 1.32 to 2.15). Costs of care increased more than the consumer price index the two years after the cancer diagnosis. Costs of care increased most for male partners and especially for younger male partners (age 25 to 64 years) of patients with colon, rectal, and lung cancers. Conclusion The results showed increased health care costs and an increase in psychiatric diagnoses after the cancer diagnosis among partners of cancer patients. Further research is needed to learn more about the situation of the partner and to identify persons at risk of psychiatric morbidity. Knowledge is also needed on how to support the partner in the most efficient way.
APA, Harvard, Vancouver, ISO, and other styles
4

Carlson, Linda E., Barry D. Bultz, Michael Speca, and Mereille St. Pierre. "Partners of Cancer Patients." Journal of Psychosocial Oncology 18, no. 2 (August 18, 2000): 39–63. http://dx.doi.org/10.1300/j077v18n02_03.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Carlson, Linda E., Barry D. Bultz, Michael Speca, and Mireille St-Pierre. "Partners of Cancer Patients." Journal of Psychosocial Oncology 18, no. 3 (September 2000): 33–43. http://dx.doi.org/10.1300/j077v18n03_03.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Veenstra, Christine M., Paul Abrahamse, Arden M. Morris, and Sarah T. Hawley. "Partner engagement and patients’ receipt of colorectal cancer surveillance." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): e19106-e19106. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e19106.

Full text
Abstract:
e19106 Background: Over 50% of survivors of colorectal cancer do not receive guideline-concordant surveillance. In light of growing recognition that members of couples influence each other’s health behaviors, we sought to describe partner engagement in surveillance and evaluate associations between partner engagement and patient receipt of surveillance. Methods: In 2019 we surveyed patients who, in 2014-18, underwent resection of Stage III colorectal cancer and were seen at a community oncology practice, an academic cancer center, or reported to Georgia SEER (current RR 46%). Patients gave a separate survey to their partner. 254 partners (68% RR) completed surveys. Using existing measures, we assessed 3 partner-reported elements of engagement: 1) informed about surveillance; 2) involved (extent of and satisfaction with) in surveillance; 3) aware of patients’ values/preferences. Each measure was scored on a continuous scale with higher scores indicating greater engagement. We assessed patient receipt of surveillance by patient-report of receipt of CEA blood test, imaging, and colonoscopy/sigmoidoscopy (all y/n response). We performed multivariable regression analyses to assess associations between each element of partner engagement and patient receipt of surveillance, controlling for important partner- and patient-level variables. Results: Most partners (85%) were > age 50, female (64%), and white (86%). 27% had <high school education. Most patients (60%) had colon primary (vs rectal), received chemotherapy (95%), and were 3-4 years out from diagnosis (62%). Female partners and those with <high school education were more likely to report a greater extent of involvement; Partners < age 50 were more likely to report greater satisfaction with involvement. Female partners, those with <high school education, and partners of patients who received chemotherapy were more likely to report greater awareness (all p < 0.05). Being informed did not vary by partner or patient factors. Having a more aware partner was associated with greater patient receipt of surveillance colonoscopy/sigmoidoscopy (p = 0.01). Receipt of surveillance CEA or imaging did not vary by partner engagement. Conclusions: Partner engagement in patients’ surveillance varied by partner age, gender and education. Partner awareness of patient preferences was associated with patient receipt of surveillance colonoscopy/sigmoidoscopy. Our findings suggest that interventions to engage partners in patients’ surveillance may improve receipt of guideline-concordant care for survivors of colorectal cancer.
APA, Harvard, Vancouver, ISO, and other styles
7

D'Souza, Gypsyamber, Neil D. Gross, Sara I. Pai, Robert Haddad, Karen S. Anderson, Shirani Rajan, Jennifer Gerber, Maura L. Gillison, and Marshall R. Posner. "Oral Human Papillomavirus (HPV) Infection in HPV-Positive Patients With Oropharyngeal Cancer and Their Partners." Journal of Clinical Oncology 32, no. 23 (August 10, 2014): 2408–15. http://dx.doi.org/10.1200/jco.2014.55.1341.

Full text
Abstract:
Purpose To better understand oral human papillomavirus (HPV) infection and cancer risk among long-term sexual partners of patients with HPV-positive oropharyngeal cancer (HPV-OPC). Patients and Methods An oral rinse sample, risk factor survey, cancer history, and oral examination (partners only) were collected from patients with HPV-OPC and their partners. Oral rinse samples were evaluated for 36 types of HPV DNA using PGMY 09/11 primers and line-blot hybridization and HPV16 copy number using quantitative polymerase chain reaction. Oral HPV prevalence was compared with infection among those age 45 to 65 years using National Health and Nutrition Examination Survey (NHANES) 2009-2010. Results A total of 164 patients with HPV-OPC and 93 of their partners were enrolled. Patients were primarily men (90%), were never-smokers (51%), and had performed oral sex (97%), with a median age of 56 years; they had a high prevalence of oncogenic oral HPV DNA (61%) and oral HPV16 DNA (54%) at enrollment. Female partners had comparable oncogenic oral HPV prevalence compared with members of the general population of the same age (1.2% v 1.3%). Among the six male partners, no oncogenic oral HPV infections were detected. No precancers or cancers were identified during partner oral cancer screening examinations. However, a history of cervical disease was reported by nine partners (10.3%) and two female patients (11.8%), and three patients (2.0%) reported a previous partner who developed invasive cervical cancer. Conclusion Oral HPV16 DNA is commonly detected among patients with HPV-OPC at diagnosis, but not among their partners. Partners of patients with HPV-OPC do not seem to have elevated oral HPV infection compared with the general population.
APA, Harvard, Vancouver, ISO, and other styles
8

McGillivray, Hannah M. K., Elisabetta E. L. Piccolo, and Richard J. Wassersug. "“Partner”, “Caregiver”, or “Co-Survivor”—Might the Label We Give the Partners of Cancer Patients Affect the Health Outcome of the Patients and Their Partners?" Current Oncology 29, no. 1 (December 27, 2021): 122–29. http://dx.doi.org/10.3390/curroncol29010010.

Full text
Abstract:
Having a life partner significantly extends survival for most cancer patients. The label given to the partners of cancer patients may, however, influence the health of not just the patients but their partners. “Caregiver” is an increasingly common label for the partners of patients, but it carries an implicit burden. Referring to partners as “caregivers” may be detrimental to the partnerships, as it implies that the individuals are no longer able to be co-supportive. Recognizing this, there has been some effort to relabel cancer dyads as “co-survivors”. However, many cancer patients are not comfortable being called a “survivor”, and the same may apply to their partners. Cancer survivorship, we argue, could be enhanced by helping keep the bond between patients and their partners strong. This includes educating patients and partners about diverse coping strategies that individuals use when facing challenges to their health and wellbeing. We suggest that preemptive couples’ counselling in cancer centers may benefit both patients and their partners.
APA, Harvard, Vancouver, ISO, and other styles
9

Veenstra, Christine M., Paul Abrahamse, Arden M. Morris, and Sarah T. Hawley. "Long-term financial outcomes and quality of life in partners of colorectal cancer survivors." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 7048. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.7048.

Full text
Abstract:
7048 Background: Many patients with colorectal cancer face financial toxicity, but little is known about financial outcomes among their partners. Moreover, virtually nothing is known about associations between partners’ quality of life and their financial outcomes. Methods: In 2019 we surveyed patients who, in 2014-18, underwent resection of Stage III colorectal cancer and were seen at a community oncology practice, an academic cancer center, or reported to Georgia SEER (current RR 46%). Patients gave a separate survey to their partner. 254 partners (68% RR) completed surveys. Partners were asked about financial impacts of the patient’s cancer. Partners’ quality of life (QOL) was measured with the PROMIS global health scale. Multivariable regression analyses of 3 partner-reported outcomes (1. Perception that their financial status is worse off, 2. Substantial worry about finances, 3. Debt related to patients’ cancer) were generated to assess associations between each outcome and key partner and patient variables, and associations between partners’ QOL and financial outcomes. Results: Among partners, 55% were < age 65, 64% female, 86% white, and 27% had < high school education. 61% were employed at time of patient’s diagnosis; 38% of those missed 7-30 days work and 13% missed > 1 month work due to the patient’s cancer. 66% patients were employed at diagnosis. Among those, 34% were no longer working at the time of survey. In 14% dyads only the patient was working at diagnosis and among those, 50% were no longer working at the time of survey. 32% partners reported their financial status is worse off, 36% reported substantial worry about finances, and 28% reported current debt, all due to the patient’s cancer. After adjustment for partner and patient variables, partners of patients further out from diagnosis and partners of patients who were working at diagnosis were more likely to report substantial worry. Partners < age 50, with <high school education, with >1 comorbid condition, and partners of patients who were working at diagnosis were more likely to report debt (all p < 0.05). Endorsing each of the 3 financial outcomes was associated with lower QOL among partners, after adjustment for partner and patient variables (all p < 0.01). Conclusions: Nearly 1/3 of partners of survivors of colorectal cancer reported long-term adverse financial outcomes due to the patient’s cancer. Partners of patients working at the time of diagnosis were more likely to report substantial worry and debt, perhaps because many patients who were working at diagnosis are no longer working in the survivorship period.
APA, Harvard, Vancouver, ISO, and other styles
10

Basu, Anirban, William Dale, Arthur Elstein, and David Meltzer. "A Time Tradeoff Method for Eliciting Partner’s Quality of Life due to Patient’s Health States in Prostate Cancer." Medical Decision Making 30, no. 3 (March 12, 2010): 355–65. http://dx.doi.org/10.1177/0272989x09349959.

Full text
Abstract:
Background. Cost-effectiveness analyses may better reflect the full costs and benefits of medical interventions if they incorporate the effects of patients’ health on their family members. Objective. To develop and apply a time tradeoff (TTO) technique to measure the impact of potential prostate cancer—related health states of the patients on the quality of life (QOL) of their partners. Methods. We developed modified TTO questions and applied them in a pilot study in which we asked the partner of the patient to tradeoff his or her own life in order to reduce the burden that he himself or she herself expects to experience if the patient developed one of the prostate cancer—related health states. We reviewed the theoretical justification for this question and carefully framed the question so as to reduce measurement error and also to avoid possible double counting with the effect on the partner’s health. Results. We collected data from 26 partners about their preferences for their own health, which is influenced by the patient’s health condition. The mean QOL weights for the partners when the patients are the following states are healthy, 0.81; impotent, 0.66; incontinent, 0.68; have metastatic disease, 0.50; and dead, 0.28. Partners’ responses varied by how close they felt to the patients. Low correlations between partners’ and patients’ QOL ratings (n = 15) suggest that the partners were not responding as proxies for the patient. Conclusions. A new TTO method is proposed to measure a partner’s QOL due to a patient’s health. Preliminary test results of validity were promising.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Partners of cancer patients"

1

Marshall, Catherine. "Breast reconstruction following cancer : its impact on patients' and partners' sexual functioning." Thesis, Lancaster University, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.421845.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Nijboer, Christine. "Caregiving to patients with colorectal cancer a longitudinal study on caregiving by partners /." [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2000. http://dare.uva.nl/document/81019.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Blakely, Hannah Virginia Caroline. "Psychological Distress and Relationship Satisfaction in Cancer Patients and the Impact of Partners." Thesis, University of Canterbury. Psychology, 2010. http://hdl.handle.net/10092/5290.

Full text
Abstract:
This study examines psychological distress and relationship satisfaction in cancer patients and their partners. It is widely recognized that spouses coping with a cancer diagnosis are at risk of psychological distress, and changes in relationship satisfaction. Debate exists within the literature regarding the level of distress and satisfaction experienced by patients, and to what extent they are influenced by their partners. Twenty six couples coping with a breast or prostate cancer diagnosis, completed two questionnaires over six months assessing: psychological distress, relationship satisfaction, attachment style, self -esteem and matching of partner ideal standards. The cross-sectional results indicate that higher patient distress was associated with their own lower levels of self esteem, less secure, and more anxious attachment styles. Patient relationship satisfaction was increased in those with a less anxious attachment style and in patients who perceived their partner as matching more closely their own ideal standards and perceptions of the patients on vitality and attractiveness. Longitudinal results show an increase in patient distress was also predicted by their partner’s perceiving lower matching between their own ideal standards and perceptions of the patients on warmth and trustworthiness. Unexpectedly, higher relationship satisfaction over time, was also predicted by lower matching of their own ideal standards and perceptions of their partners on warmth and trustworthiness, as measured initially. An increase in patient satisfaction was also predicted over time when patient distress was low, self esteem high and they had higher matching between their own ideal standards and partner perceptions of the patient partner on both warmth and trustworthiness as well as vitality and attractiveness. Explanations for the results, together with clinical and research implications are discussed.
APA, Harvard, Vancouver, ISO, and other styles
4

Pikler, Vanessa I. Brown Chrisanthia. "The influence of gender role socialization on cancer patients' and partners' psychological distress and quality of life." Diss., UMK access, 2006.

Find full text
Abstract:
Thesis (Ph. D.)--School of Education. University of Missouri--Kansas City, 2006.
"A dissertation in counseling psychology." Advisor: Chrisanthia Brown. Typescript. Vita. Title from "catalog record" of the print edition Description based on contents viewed Nov. 13, 2007. Includes bibliographical references (leaves 94-103). Online version of the print edition.
APA, Harvard, Vancouver, ISO, and other styles
5

Wanat, Marta. "Experiences of patients and of partners of patients with a recurrence of colorectal cancer : a qualitative longitudinal study." Thesis, Oxford Brookes University, 2015. https://radar.brookes.ac.uk/radar/items/9912e10c-df4d-4a31-b87e-7fddc97f4017/1/.

Full text
Abstract:
Colorectal cancer is the fourth most common cancer type in the UK. Following treatment, many patients will recover and be considered cured. However, this is not the case for all patients and some will face a recurrence of their cancer. This PhD aimed to explore the experiences of patients and partners of patients when colorectal cancer recurs. A meta-ethnography and literature review were conducted to examine the existing research evidence on the experiences of patients and of partners, respectively, at the time of recurrence. While these reviews provided some insights, they also highlighted the lack of studies exploring this important phase in the cancer journey. Interpretative Phenomenological Analysis (IPA) was chosen as a methodology to explore in depth the experiences of patients and partners. A longitudinal design was used to capture changes in participants’ experiences. Analysis of interviews with six patients with colorectal cancer recurrence and five partners revealed that the initial diagnosis was an important framework for making sense of the diagnosis of recurrence. Specifically, participants compared the treatment options, quality of care and prognosis at the time of recurrence to those at initial diagnosis which, in turn, could either magnify or lessen their distress. Patients faced challenges in sharing their experience, including their emotions and information on their illness. Partners also struggled to share their experiences with other people, but these challenges were mainly related to the physical and emotional burden of caring. Finally, the study also highlighted that the diagnosis of recurrence disrupted previous rhythms of life for both patients and partners. While patients’ accounts focused on ways of negotiating the place of cancer in their lives within the context of coping with physical suffering, partners also grieved the loss of a previous relationship with a patient. This PhD captures the difficult experience of colorectal cancer recurrence for patients and partners, and the complex psychological processes that underpin this experience. The findings have clinical implications regarding information and supportive care provision and may help to inform further development of health care services for patients with colorectal cancer recurrence and their partners.
APA, Harvard, Vancouver, ISO, and other styles
6

Ash, Kristen M. "Language Style Matching as a Predictor of Successful Coping in Breast Cancer Patients and Their Partners." Thesis, The University of Arizona, 2012. http://hdl.handle.net/10150/243736.

Full text
Abstract:
Past research has shown that the use of function words--such as pronouns--in Language Style Matching accurately predicts relationship satisfaction and success. The current study on breast cancer patients focuses on two main hypotheses. First, we predicted that LSM would correlate positively with relationship satisfaction and this correlation would be unique to the patient-partner relationship. Second, it follows that LSM would positively correlate with successful use of coping mechanisms for breast cancer patients and their partners. We operationalized coping through two questionnaires, the dyadic adjustment scale (DAS) and the center for epidemiological studies depression scale (CES-D), assessed longitudinally. The linguistic inquiry word count program (LIWC) software measured LSM by counting function words obtained by the objective sound clips recorded by an electronically activated recorder (EAR). Cancer patients and their partners exhibited high LSM and overall variance was low (.001) within couples (.002) and between friends and family (.061). Personal pronouns correlate with overall satisfaction as reported by partners. Conversely, LSM within couples did not predict depression in partners or patients. Results suggest that in the matter of cancer patients and their partners’ self reported adjustment LSM does not significantly matter.
APA, Harvard, Vancouver, ISO, and other styles
7

Mohd, Naim Noor Faizah. "Armus dual roles in autophagy and E-cadherin degradation : distinct partners, regulation and implications for cancer patients." Thesis, Imperial College London, 2015. http://hdl.handle.net/10044/1/47979.

Full text
Abstract:
Cancer is one of the leading causes of mortality worldwide. Invasion, metastasis and apoptotic evasion are cancer hallmarks. Tumour cell metastasis requires loss of E-cadherin cell-cell adhesion receptor. Apoptotic evasion can be mediated by up-regulation of autophagy, which maintains cellular energy during metabolic stress in cancer cells. Armus is a TBC/RabGAP protein that regulates both E-cadherin degradation and autophagy by controlling lysosome fusion with late vesicular compartments or autophagosomes. Understanding Armus function in these degradative processes during tumourigenesis may lead to combinatorial inhibition of oncogenic pathways and novel therapeutic targets. Here I address: (i) whether Armus participates in E-cadherin deregulation downstream of oncogenes, (ii) potential mechanisms through which Armus can switch between its function at junctions and autophagosomes and (iii) potential strategies to inhibit Armus intracellular localisation. I found that Armus is involved in Src and H-Ras disruption of E-cadherin junctions in keratinocytes. Armus binds to α-catenin at junctions, while at autophagosomes Armus interacts with autophagy marker, LC3. Incubation with Armus peptides containing LC3-interacting motifs partially blocks Armus function in autophagy. Mutation of the specific residues mediating α-catenin association reduces Armus localisation at cell-cell contacts. The close juxtaposition of LC3 and α-catenin binding at PH domain at Armus N-terminus may suggest additional roles. Armus N-terminus and RabGAP domain interact directly, and residue K480 is critical for binding. This intramolecular interaction may form a closed conformation, and Armus activation may require the release of this auto-inhibition. It is tempting to suggest that protein interactions at the PH domain such as LC3 and α-catenin may modulate Armus auto-inhibition. Alternatively, the phosphoinositide repertoire interacting with the PH domain may contribute to Armus intracellular distribution and activation. Further insights into Armus activation may provide greater understanding of its function in distinct cellular events with implications for tumourigenesis.
APA, Harvard, Vancouver, ISO, and other styles
8

Jenick, Marcus, and n/a. "Couples Coping With End-Stage Cancer: The Influence of Attachment, Emotional Support, and Positive Meaning on Psychological Adjustment and Each Other." Griffith University. School of Applied Psychology, 2003. http://www4.gu.edu.au:8080/adt-root/public/adt-QGU20030804.121524.

Full text
Abstract:
This thesis was concerned with the psychological adjustment of 67 end-stage cancer patients, and three psychosocial variables considered to influence that adjustment: emotional support from spouse, positive meaning, and working models of attachment. Furthermore, this thesis was also concerned with the psychological adjustment of the patients' spouses, and the influence of emotional support from patient and working models of attachment on their adjustment. It was hypothesised that each of these psychosocial variables would directly influence the psychological adjustment of patients and spouses, measured using the negative affectivity scale of the Positive and Negative Affect Scale (PANAS). Furthermore, it was hypothesised that emotional support would influence positive meaning, and working models of attachment would influence both emotional support and positive meaning. Variables were measured via paper and pencil self-report inventories, with the exception of positive meaning, where verbal responses to an open question were coded. Univariate analyses indicated an association between patients' and spouses' emotional support provided by one another and their psychological adjustment. Univariate results also showed that patients' positive meaning was related to patients' psychological adjustment, and that patients' working models of attachment involving higher levels of attachment anxiety were associated with patients' poorer psychological adjustment. All these individual associations remained statistically significant after three control variables related to the patients' physical condition were taken into account. In addition, univariate analyses indicated that attachment was associated with emotional support, and that emotional support was associated with positive meaning. Following univariate analyses, variables were integrated into one model for patients and another for spouses using path analyses. Results were generally consistent with the prior sets of analyses. However, patients' working models of attachment involving higher levels of attachment anxiety no longer had a direct effect on patients' psychological adjustment to statistically significant levels. Rather, the influence of the working models of attachment on patients' psychological adjustment was mediated by emotional support. In addition, patients' positive meaning no longer had a significant direct effect on patients' psychological adjustment. The insignificant path coefficients between attachment anxiety and psychological adjustment, and between positive meaning and psychological adjustment, were attributed to the large amount of variance in negative affect due to emotional support. In summary, this research indicates that emotional support given and received between patients and spouses is important to the psychological adjustment of each party. Furthermore, emotional support influences patients' ability to construe positive meaning in their illness, although positive meaning does not appear to be as critical to the psychological adjustment of patients as emotional support. Working models of attachment influence the psychological adjustment of patients primarily through their influence on emotional support.
APA, Harvard, Vancouver, ISO, and other styles
9

Jenick, Marcus. "Couples Coping With End-Stage Cancer: The Influence of Attachment, Emotional Support, and Positive Meaning on Psychological Adjustment and Each Other." Thesis, Griffith University, 2003. http://hdl.handle.net/10072/365492.

Full text
Abstract:
This thesis was concerned with the psychological adjustment of 67 end-stage cancer patients, and three psychosocial variables considered to influence that adjustment: emotional support from spouse, positive meaning, and working models of attachment. Furthermore, this thesis was also concerned with the psychological adjustment of the patients' spouses, and the influence of emotional support from patient and working models of attachment on their adjustment. It was hypothesised that each of these psychosocial variables would directly influence the psychological adjustment of patients and spouses, measured using the negative affectivity scale of the Positive and Negative Affect Scale (PANAS). Furthermore, it was hypothesised that emotional support would influence positive meaning, and working models of attachment would influence both emotional support and positive meaning. Variables were measured via paper and pencil self-report inventories, with the exception of positive meaning, where verbal responses to an open question were coded. Univariate analyses indicated an association between patients' and spouses' emotional support provided by one another and their psychological adjustment. Univariate results also showed that patients' positive meaning was related to patients' psychological adjustment, and that patients' working models of attachment involving higher levels of attachment anxiety were associated with patients' poorer psychological adjustment. All these individual associations remained statistically significant after three control variables related to the patients' physical condition were taken into account. In addition, univariate analyses indicated that attachment was associated with emotional support, and that emotional support was associated with positive meaning. Following univariate analyses, variables were integrated into one model for patients and another for spouses using path analyses. Results were generally consistent with the prior sets of analyses. However, patients' working models of attachment involving higher levels of attachment anxiety no longer had a direct effect on patients' psychological adjustment to statistically significant levels. Rather, the influence of the working models of attachment on patients' psychological adjustment was mediated by emotional support. In addition, patients' positive meaning no longer had a significant direct effect on patients' psychological adjustment. The insignificant path coefficients between attachment anxiety and psychological adjustment, and between positive meaning and psychological adjustment, were attributed to the large amount of variance in negative affect due to emotional support. In summary, this research indicates that emotional support given and received between patients and spouses is important to the psychological adjustment of each party. Furthermore, emotional support influences patients' ability to construe positive meaning in their illness, although positive meaning does not appear to be as critical to the psychological adjustment of patients as emotional support. Working models of attachment influence the psychological adjustment of patients primarily through their influence on emotional support.
Thesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Applied Psychology
Full Text
APA, Harvard, Vancouver, ISO, and other styles
10

Rees, Jonathan. "Measurement of response shift in quality of life and symptom assessment in patients with advanced prostate cancer and their partners." Thesis, University of Bristol, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.398668.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Partners of cancer patients"

1

Haddad, Peter Michael. Affective disorders in the partners of cancer patients. Manchester: University of Manchester, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

A visible wound: A healing journey through breast cancer : with practical and spiritual guidance for women, their partners, and families. Dorset: Element, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kneece, Judy C. Breast cancer support partner handbook: Tips for becoming an effective support partner. 8th ed. North Charleston, SC: EduCare, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Breast cancer support partner handbook: Tips for becoming an effective support partner. 7th ed. North Charleston, SC: EduCare, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Prostate cancer and the man you love: Supporting and caring for your partner. Lanham: Rowman & Littlefield Publishers, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kneece, Judy C. Helping your mate facer breast cancer: Tips for becoming an effective support partner for the one you love during the breast cancer experience. Columbia, SC: EduCare Pub., 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Timmermann, Carsten, and Elizabeth Toon, eds. Cancer Patients, Cancer Pathways. London: Palgrave Macmillan UK, 2012. http://dx.doi.org/10.1057/9781137272089.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Council on Community Health, Hospital, Institutional, and Medical Affairs. Ad Hoc Committee on Protocol Development. Patients receiving cancer chemotherapy. Chicago, Ill: American Dental Association, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ebell, Hansjörg. Pain management in cancer patients. Stuttgart ; New York: G. Thieme Verlag ; New York : Thieme Medical Publishers, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

National Cancer Institute (U.S.). Eating hints for cancer patients. [Bethesda, MD]: National Cancer Institute, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Partners of cancer patients"

1

Möhring, P., and E. Brähler. "Body Complaints Among Recovered Genital Cancer Patients and Their Partners." In Body Experience, 177–86. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73412-0_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Fleming, Kathryn M., Matthias Klammer, and Mickey B. C. Koh. "Laboratory/Pathology Services and Blood Bank." In The Comprehensive Cancer Center, 63–74. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-82052-7_8.

Full text
Abstract:
AbstractPathology and its laboratories are central in support of every facet of cancer care in a CCC center, from diagnosis, to patient support during treatment, research, therapeutic drug manufacture and development and bio-banking.We have approached this discussion from the perspective of the timeline of a patient’s journey through cancer care. We begin with screening programs, high quality diagnostics and then maintaining quality supportive cancer care. Specialised services such as cellular therapies and haematopoietic stem cell transplantation with their unique requirements are considered and lastly we discuss the vital role of clinical trials and research in comprehensive cancer care with a focus on biobanks.We also examine the role of the diagnostic laboratories and their clinical and scientific staff in shaping an integrated cancer diagnostic report, as an integral part of a cancer Multidisciplinary Team (MDT) or “Tumour Board”. Increasingly, integration of a large amount of clinical data, laboratory results and interpretation of complex molecular and genomic datasets is required to underpin the role of CCC’s as centres of clinical excellence and to collaborate with partners in local, national and international research protocols.
APA, Harvard, Vancouver, ISO, and other styles
3

Kayser, Karen. "Enhancing Dyadic Coping During a Time of Crisis: A Theory-Based Intervention With Breast Cancer Patients and Their Partners." In Couples coping with stress: Emerging perspectives on dyadic coping., 175–94. Washington: American Psychological Association, 2005. http://dx.doi.org/10.1037/11031-009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Britnell, Mark. "Patients As Partners." In In Search of the Perfect Health System, 186–93. London: Macmillan Education UK, 2015. http://dx.doi.org/10.1007/978-1-137-49662-1_31.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Fan, Timothy M. "Cancer Patients." In Veterinary Anesthesia and Analgesia, 993–1003. Chichester, UK: John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119421375.ch55.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Deixonne, B. "Treated Patients." In Exocrine Pancreatic Cancer, 201–8. Berlin, Heidelberg: Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-71178-7_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

De Conno, F., and K. Foley. "Elderly patients." In Cancer Pain Relief, 39. Dordrecht: Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0099-1_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Timmermann, Carsten, and Elizabeth Toon. "Introduction." In Cancer Patients, Cancer Pathways, 1–9. London: Palgrave Macmillan UK, 2012. http://dx.doi.org/10.1057/9781137272089_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Zuiderent-Jerak, Teun, Roland Bal, and Marc Berg. "Patients and their Problems: Situated Alliances of Patient-Centred Care and Pathway Development." In Cancer Patients, Cancer Pathways, 204–29. London: Palgrave Macmillan UK, 2012. http://dx.doi.org/10.1057/9781137272089_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Pickstone, John. "Radicalism, Neoliberalism and Biographical Medicine: Constructions of English Patients and Patient Histories Around 1980 and Now." In Cancer Patients, Cancer Pathways, 230–55. London: Palgrave Macmillan UK, 2012. http://dx.doi.org/10.1057/9781137272089_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Partners of cancer patients"

1

Brundage, S., D. Charles Chisholm, JN Holloway, W. Lucas, J. Salamone, S. Winarsky, M. London, et al. "Abstract P5-10-01: Patient advocates as partners in breast cancer research at Georgetown University Lombardi Comprehensive Cancer Center." In Abstracts: Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 8-12, 2015; San Antonio, TX. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.sabcs15-p5-10-01.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Xu, Shenmeng, Peiran Guo, Gail Patricia Fuller, Cloie Ann Dobias, Eno Idiagbonya, and Lixin Song. "Abstract PO-176: Neighborhood deprivation and living with prostate cancer: Patients' and partners' psychosocial behavioral status, symptoms, and quality of life." In Abstracts: AACR Virtual Conference: 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; October 6-8, 2021. American Association for Cancer Research, 2022. http://dx.doi.org/10.1158/1538-7755.disp21-po-176.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Cho, Dalnim, Karen Basen-Engquist, Richard Simpson, Hilary Ma, Curtis Pettaway, Yisheng Li, Steven Canfield, et al. "Abstract A053: Watchful Living: A pilot lifestyle intervention for African American and Hispanic prostate cancer patients on active surveillance and their partners." In Abstracts: Eleventh AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; November 2-5, 2018; New Orleans, LA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7755.disp18-a053.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ji, Yan, Tanay Samant, Michelle Quinlan, and Abhijit Chakraborty. "Abstract P1-19-37: Pharmacokinetic assessment of ribociclib, an oral CDK4/6 inhibitor, and the interaction with endocrine therapy partners in patients with advanced breast cancer." In Abstracts: 2019 San Antonio Breast Cancer Symposium; December 10-14, 2019; San Antonio, Texas. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.sabcs19-p1-19-37.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ó, Júlia R. S. do, Joaquim F. Fernandes, Rafael C. E. Segato, Frank L. B. Rodrigues, Ana Cláudia G. Lima, Nilceana M. A. Freitas, Deidimar C. B. Abreu, and Leandro G. Oliveira. "PALB2 MUTATION IN A 31-YEAR-OLD WOMAN: A CASE REPORT." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2039.

Full text
Abstract:
Introduction: Oncogenetics advances allow to identifying the relationship between many genes and breast cancer (BC). The PALB2 (partner and localizer of BRCA2) gene is intimately involved in DNA damage response, and although very rare, heterozygous mutations are highly penetrant for BC. There are not enough studies to define the ideal follow-up and management of the patients with BC. Case Report: A 31-year-old female, G0P0A0, presents complaining of a lump in her right breast with no family history of cancer. A breast ultrasound was performed and revealed BI-RADS3. Core biopsy revealed a grade 3 ductal infiltrate carcinoma, with micropapillary features. Immunohistochemistry testing detected estrogen receptor (100%), progesterone receptor (3%), negative HER2 (−), and Ki67 (proliferation marker) (15%). The patient presented with a breast mass (8 cm × 8 cm), nipple inversion, and clinically was N1. Magnetic resonance imaging of the breast showed right axillary lymph node enlargement of 1.1´1.6 cm, and retroareolar and lateral quadrants of the right breast distortions. Because of diffuse skin thickening and nipple retraction, the disease was classified as cT4N1. She received neoadjuvant chemotherapy (weekly paclitaxel followed by dose-dense doxorubicin and cyclophosphamide) with concomitant ovarian suppression. Genetic testing for ovarian cancer and BC found the pathogenic variant c.2164_2168del, p. (Met723Valfs*21), in heterozygosity in the PALB2 gene and interpreted based on the clinical picture and the classification of variants of the American College of Medical Genetics. A right mastectomy with pathologic complete response in the breast and a micrometastasis node 1.5 mm/10 (ypT0N1mic) was conducted. Prophylactic left adenomastectomy was negative for malignancy. In the adjuvant setting, radiotherapy and endocrine therapy with ovarian suppression and aromatase inhibitor for 5 years were scheduled. Conclusion: The critical role of PALB2 in DNA repair increases the risk for BC and contralateral BCs. There is no evidence of adverse outcomes or toxicity with the use of radiotherapy in PALB2 carriers. Locoregional management and prophylactic decisions should be made on the basis of conventional clinicopathologic factors and international guidelines recommendations.
APA, Harvard, Vancouver, ISO, and other styles
6

Vanlemmens, L., A. Congard, P. Antoine, E. Fournier, A. Lesur, C. Loustalot, C. Guillemet, et al. "Abstract P3-09-07: Construction of two quality of life questionnaires from young breast cancer patients and their partner." In Abstracts: Thirty-Sixth Annual CTRC-AACR San Antonio Breast Cancer Symposium - Dec 10-14, 2013; San Antonio, TX. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/0008-5472.sabcs13-p3-09-07.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Verschuur, E., D. Collyar, Mv Oirsouw, D. Pinto, H. Stobart, and M. Wilcox. "Abstract P5-17-02: Patient advocates are partners in global breast research: Value is recognised by early advocate involvement in the PREvent ductal carcinoma in situ invasive overtreatment now (PRECISION) study and related trials." In Abstracts: 2017 San Antonio Breast Cancer Symposium; December 5-9, 2017; San Antonio, Texas. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.sabcs17-p5-17-02.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Jetelina, Katelyn. "56 The impact of intimate partner violence on breast and cervical cancer treatment among patients in an integrated, safety-net setting." In Society for the Advancement of Violence and Injury Research (SAVIR) 2020 conference abstracts. BMJ Publishing Group Ltd, 2020. http://dx.doi.org/10.1136/injuryprev-2020-savir.10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Abraham, J., A.-L. Vallier, W. Qian, A. Machin, L. Grybowicz, S. Thomas, M. Weiss, et al. "Abstract OT3-03-03: PARTNER: Randomised, phase II/III trial to evaluate the safety and efficacy of the addition of olaparib to platinum-based neoadjuvant chemotherapy in triple negative and/or germline BRCA mutated breast cancer patients." In Abstracts: 2018 San Antonio Breast Cancer Symposium; December 4-8, 2018; San Antonio, Texas. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-ot3-03-03.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Abraham, JE, A.-L. Vallier, W. Qian, L. Grybowicz, S. Thomas, S. Mahmud, C. Harvey, et al. "Abstract OT2-01-15: PARTNER - Randomised, phase II/III trial to evaluate the safety and efficacy of the addition of olaparib to platinum-based neoadjuvant chemotherapy in triple negative and/or germline BRCA mutated breast cancer patients." In Abstracts: 2016 San Antonio Breast Cancer Symposium; December 6-10, 2016; San Antonio, Texas. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.sabcs16-ot2-01-15.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Partners of cancer patients"

1

Zakowski, Sandra G. Improving Quality of Life in Ovarian Cancer Patients: A Brief Intervention for Patients and Their Partners. Fort Belvoir, VA: Defense Technical Information Center, September 2004. http://dx.doi.org/10.21236/ada428535.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Zakowski, Sandra G. Improving Quality of Life in Ovarian Cancer Patients: A Brief Intervention for Patients and Their Partners. Fort Belvoir, VA: Defense Technical Information Center, September 2002. http://dx.doi.org/10.21236/ada411727.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Zakowski, Sandra G. Improving Quality of Life in Ovarian Cancer Patients: A Brief Intervention for Patients and Their Partners. Fort Belvoir, VA: Defense Technical Information Center, September 2003. http://dx.doi.org/10.21236/ada420807.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Zakowski, Sandra G. Improving Quality of Life in Ovarian Cancer Patients: A Brief Intervention for Patients and their Partners. Fort Belvoir, VA: Defense Technical Information Center, September 2006. http://dx.doi.org/10.21236/ada477084.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Zakowski, Sandra G. Improving Quality of Life in Ovarian Cancer Patients: A Brief Intervention for Patients and Their Partners. Fort Belvoir, VA: Defense Technical Information Center, September 2007. http://dx.doi.org/10.21236/ada478017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Zakowski, Sandra G. Emotional Expression and Psychological Adjustment to Prostate Cancer: A Brief Intervention for Patients and Their Partners. Fort Belvoir, VA: Defense Technical Information Center, February 2005. http://dx.doi.org/10.21236/ada435610.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Zakowski, Sandra G. Emotional Expression and Psychological Adjustment to Prostate Cancer: A Brief Intervention for Patients and their Partners. Fort Belvoir, VA: Defense Technical Information Center, February 2002. http://dx.doi.org/10.21236/ada405322.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zakowski, Sandra G. Emotional Expression and Psychological Adjustment to Prostate Cancer: A Brief Intervention for Patients and Their Partners. Fort Belvoir, VA: Defense Technical Information Center, February 2003. http://dx.doi.org/10.21236/ada415607.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Zakowski, Sandra G. Emotional Expression and Psychological Adjustment to Prostate Cancer: A Brief Intervention for Patients and Their Partners. Fort Belvoir, VA: Defense Technical Information Center, February 2004. http://dx.doi.org/10.21236/ada425104.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Armstrong, Katrina. Treatment Decisions in Localized Prostate Cancer: Patient, Partner and Physician. Fort Belvoir, VA: Defense Technical Information Center, April 2001. http://dx.doi.org/10.21236/ada394110.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Partners of cancer patients' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography